3-(4-Nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 95.0%, 1g

Methyl 2-(1,3-dioxo-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-4-yl)acetate, 97%, 100mg

5-Bromo-2-methoxyisonicotinic acid, 95.0%, 250mg

N-Cyclopropyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 96%, 1g

2-Bromo-5-chloroquinazoline, 98%, 250mg

Ethyl 8-bromoquinoline-4-carboxylate, 95+%, 100mg

Ethyl 3,3,3-Trifluoropropionate, 97.0%, 10g

4-(1H-pyrazol-1-yl)-2-butanone, 95.0%, 1g

5-Amino-6-bromopyridine-2-carboxylic acid, 95%, 1g

2-Amino-5-bromo-3-methoxybenzoic acid, 95.0%, 5g

Aiguilles Pointe type 2 pour seringues GASTIGHT® série 1700, Gesch. pour, <= 100 μl, 6 pièces

3-Chloro-1H-pyrazol-4-amine hydrochloride, 95.0%, 25g

5-Acetyl-2-(4-bromophenoxy) pyridine, 95%, 250mg